Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 21-Jun-23 6:21 PM View:  | Xencor Inc (XNCR) | 20-Jun-23 | Grant | 5,007 | -- | -- | 100% 0 to 5.01K | |
| 01-Feb-13 4:51 PM View: | Dendreon Corp. (DNDN) | 31-Jan-13 | Payment of Exercise | 580 | $5.88 | $3,410.40 | (< 1%) 225.41K to 224.83K | 98% |
| 23-Jan-13 3:18 PM View: | Dendreon Corp. (DNDN) | 20-Jan-13 | Payment of Exercise | 348 | $6.31 | $2,195.88 | (< 1%) 225.76K to 225.41K | 98% |
| 07-Jan-13 5:23 PM View: | Dendreon Corp. (DNDN) | 03-Jan-13 | Payment of Exercise | 14,443 | $5.79 | $83,625.00 | (6%) 240.2K to 225.76K | 98% |
| 01-Nov-12 6:46 PM View: | Dendreon Corp. (DNDN) | 31-Oct-12 | Payment of Exercise | 580 | $3.80 | $2,204.00 | (< 1%) 240.78K to 240.2K | 97% |
| 23-Oct-12 2:31 PM View: | Dendreon Corp. (DNDN) | 20-Oct-12 | Payment of Exercise | 348 | $4.33 | $1,506.84 | (< 1%) 241.13K to 240.78K | 97% |
| 01-Aug-12 4:21 PM View: | Dendreon Corp. (DNDN) | 31-Jul-12 | Payment of Exercise | 580 | $4.76 | $2,760.80 | (< 1%) 241.71K to 241.13K | 98% |
| 24-Jul-12 2:39 PM View: | Dendreon Corp. (DNDN) | 20-Jul-12 | Payment of Exercise | 348 | $6.52 | $2,268.96 | (< 1%) 242.06K to 241.71K | 98% |
| 01-May-12 4:51 PM View: | Dendreon Corp. (DNDN) | 30-Apr-12 | Payment of Exercise | 578 | $11.65 | $6,733.70 | (< 1%) 242.64K to 242.06K | 99% |
| 24-Apr-12 12:04 PM View: | Dendreon Corp. (DNDN) | 20-Apr-12 | Payment of Exercise | 347 | $10.35 | $3,591.45 | (< 1%) 242.98K to 242.64K | 99% |
| 02-Feb-12 6:30 PM View: | Dendreon Corp. (DNDN) | 31-Jan-12 | Payment of Exercise | 796 | $13.58 | $10,809.70 | (< 1%) 253.78K to 252.98K | 99% |
| 24-Jan-12 2:49 PM View: | Dendreon Corp. (DNDN) | 20-Jan-12 | Payment of Exercise | 1,917 | $13.37 | $25,630.30 | (< 1%) 255.7K to 253.78K | 99% |
| 05-Jan-12 6:37 PM View: | Dendreon Corp. (DNDN) | 03-Jan-12 | Grant | 200,000 | -- | -- | 359% 55.7K to 255.7K | |
| 01-Nov-11 7:12 PM View: | Dendreon Corp. (DNDN) | 31-Oct-11 | Payment of Exercise | 796 | $10.94 | $8,708.24 | (1%) 56.49K to 55.7K | 99% |
| 02-Aug-11 5:58 PM View: | Dendreon Corp. (DNDN) | 31-Jul-11 | Payment of Exercise | 796 | $36.90 | $29,372.40 | (1%) 57.29K to 56.49K | 100% |
| 31-May-11 6:10 PM View: | Dendreon Corp. (DNDN) | 26-May-11 | Market Sale | 6,371 | $41.00 | $261,211.00 | (10%) 63.66K to 57.29K | 100% |
| 03-May-11 7:33 PM View: | Dendreon Corp. (DNDN) | 30-Apr-11 | Payment of Exercise | 2,379 | $42.27 | $100,561.00 | (4%) 66.04K to 63.66K | 100% |
| 24-Jan-11 8:18 PM View: | Dendreon Corp. (DNDN) | 20-Jan-11 | Grant | 21,038 | -- | -- | 47% 45.0K to 66.04K | |
| 09-Dec-10 8:42 PM View: | Dendreon Corp. (DNDN) | 07-Dec-10 | Grant | 10,000 | -- | -- | 29% 35.0K to 45.0K | |
| 04-May-10 5:37 PM View: | Dendreon Corp. (DNDN) | 30-Apr-10 | Grant | 35,000 | -- | -- | 100% 0 to 35.0K | |
| 22-Oct-09 5:11 PM View: | Sepracor, Inc. (SEPR) | 20-Oct-09 | Disposition | 61,667 | $23.00 | $1,418,340.00 | (100%) 61.67K to 0 | < 1% |
| 19-Oct-09 5:22 PM View: | Sepracor, Inc. (SEPR) | 15-Oct-09 | Disposition (change in control) | 13,333 | $23.00 | $306,659.00 | (18%) 75.0K to 61.67K | < 1% |
| 14-May-09 9:48 PM View: | Sepracor, Inc. (SEPR) | 14-May-09 | Grant | 35,000 | $14.40 | $504,000.00 | 88% 40.0K to 75.0K | < 1% |
| 20-Aug-08 5:02 PM View: | Sepracor, Inc. (SEPR) | 19-Aug-08 | Grant | 40,000 | $18.06 | $722,400.00 | 100% 0 to 40.0K | (19%) |
| 14-Feb-08 5:23 PM View: | Neurocrine Biosciences Inc. (NBIX) | 12-Feb-08 | Market Sale | 9,366 | $5.02 | $47,019.00 | (48%) 19.33K to 9.97K | (2206%) |
| 14-Feb-08 5:23 PM View: | Neurocrine Biosciences Inc. (NBIX) | 12-Feb-08 | Market Sale (Planned) | 300 | $5.17 | $1,551.00 | (3%) 9.97K to 9.67K | (2139%) |
| 22-Jun-05 7:29 PM View: | Neurocrine Biosciences Inc. (NBIX) | 20-Jun-05 | Grant | 5,000 | $42.40 | $212,000.00 | 100% 0 to 5.0K | 173% |
| 22-Apr-05 2:32 PM View: | Genencor International Inc (GCOR) | 20-Apr-05 | Disposition (change in control) | 7,000 | $19.25 | $134,750.00 | (100%) 7.0K to 0 |